Columbia Unv/Dystonia Med New York City, NY - 10032

Columbia Unv/Dystonia Med is categorized under Hospital, Medical School Affiliation in New York City, NY and active since 1961.

Columbia Unv/Dystonia Med was established in 1961, and today employs 1 to 4, earning Unknown per year. This is a Hospital, Medical School Affiliation business, which does work in the B2C market, and is classified as a Hospital, Medical School Affiliation, under code number 622110 by the NAICS.

If you are seeking more information, feel free to contact Lewis Rowland at the company’s single location by writing to 710 West 168th St Room 1103, New York City, New York NY 10032 or by phoning (212) 305-1540. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Columbia Unv/Dystonia Med
Contact Person: Lewis Rowland
Address: 710 West 168th St Room 1103, New York City, New York 10032
Phone Number: (212) 305-1540
Annual Revenue (USD): Unknown
Founded: 1961
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hospital, Medical School Affiliation
SIC Code: 8062
NAICS Code: 622110
Share This Business:

Columbia Unv/Dystonia Med was started in 1961 to provide professional Hospital, Medical School Affiliation under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Lewis Rowland for inquiries that concern Columbia Unv/Dystonia Med by calling the company number (212) 305-1540, as your correspondence is most welcome. Additionally, the physical location of the single location of Columbia Unv/Dystonia Med can be found at the coordinates as well as the street address 710 West 168th St Room 1103 in New York City, New York 10032.

For its online presence, you may visit Columbia Unv/Dystonia Med’s website at and engage with its social media outlets through on Twitter and on Facebook.